Litcius/Paper detail

Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial

Dibya Lochan Praharaj, Madhumita Premkumar, Akash Roy, Nipun Verma, Sunil Taneja, Ajay Duseja, Radha K. Dhiman

2021Journal of Clinical and Experimental Hepatology35 citationsDOIOpen Access PDF

Topics & Concepts

RifaximinMedicineSpontaneous bacterial peritonitisNorfloxacinClinical endpointHepatic encephalopathyInternal medicineCirrhosisAntibiotic prophylaxisGastroenterologyRandomized controlled trialAntibioticsCiprofloxacinMicrobiologyBiologyLiver Disease and TransplantationSepsis Diagnosis and TreatmentAmoebic Infections and Treatments
Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial | Litcius